Loerop James (CIK 0001781549)

Latest company ownership

ACRS - Aclaris Therapeutics, Inc.
Role: Chief Business Officer
Shares held
292,300
Last filed at
Feb 4, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2023Q1 2025Q4
ANIK - Anika Therapeutics, Inc.
Role: EVP Business Development
Shares held
3,000
Last filed at
Jul 12, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 1, 2025 Feb 4, 2025 Aclaris Therapeutics, Inc. Chief Business Officer Sell 46.3 -15,447 -13.01% ✗ $38.3K
Dec 31, 2024 Jan 3, 2025 Aclaris Therapeutics, Inc. Chief Business Officer Sell 42.5 -40,664 -20.17% ✗ $100.8K
Feb 1, 2024 Feb 5, 2024 Aclaris Therapeutics, Inc. Chief Business Officer Sell 47.5 -6,421 -9.24% ✗ $7.7K
Aug 28, 2023 Aug 28, 2023 Aclaris Therapeutics, Inc. Chief Business Officer Buy 95.0 +14,705 210.58% ✗ $100K
Feb 8, 2023 Feb 10, 2023 Aclaris Therapeutics, Inc. Chief Business Officer Sell 42.5 -4,267 -37.93% ✗ $59.3K
Jul 8, 2021 Jul 12, 2021 Anika Therapeutics, Inc. EVP Business Development Sell 46.3 -731 -11.56% ✗ $31.6K
Jul 8, 2020 Jul 10, 2020 Anika Therapeutics, Inc. EVP Business Development Sell 91.3 +1,756 100.00% ✗ $43.7K